Gilead Sciences
GILD
#129
Rank
S$194.91 B
Marketcap
S$157.09
Share price
-1.14%
Change (1 day)
28.51%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of September 2025 : S$9.52 Billion

According to Gilead Sciences's latest financial reports the company has S$9.52 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$15.72 B63.9%
2023-12-31S$9.59 B12.08%
2022-12-31S$8.55 B-2.89%
2021-12-31S$8.81 B-10.06%
2020-12-31S$9.80 B-70.15%
2019-12-31S$32.83 B-20.13%
2018-12-31S$41.10 B20.48%
2017-12-31S$34.11 B98.19%
2016-12-31S$17.21 B-16.68%
2015-12-31S$20.66 B54.4%
2014-12-31S$13.38 B395.43%
2013-12-31S$2.70 B18.61%
2012-12-31S$2.27 B-82.24%
2011-12-31S$12.82 B374.28%
2010-12-31S$2.70 B16.21%
2009-12-31S$2.32 B-9.13%
2008-12-31S$2.55 B51.79%
2007-12-31S$1.68 B17.4%
2006-12-31S$1.43 B-62.67%
2005-12-31S$3.84 B88.08%
2004-12-31S$2.04 B70.32%
2003-12-31S$1.20 B-26.54%
2002-12-31S$1.63 B51.55%
2001-12-31S$1.07 B21.38%
2000-12-31S$0.88 B81.35%
1999-12-31S$0.49 B193.66%
1998-12-31S$0.16 B209.38%
1997-12-31S$53.95 M-70.79%
1996-12-31S$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
S$12.23 B 28.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$8.14 B-14.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.34 B-22.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.65 B-82.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$5.13 B-46.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$19.41 B 103.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$24.05 B 152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$12.84 B 34.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.60 B 147.84%๐Ÿ‡บ๐Ÿ‡ธ USA